Meetings, Conferences, & Workshops | Drugs
Meetings, conferences, and workshops sponsored or co-sponsored by Center for Drug Evaluation and Research.
As with any medicine, the MHRA will keep the safety and effectiveness of teplizumab under close review.
Use this form to transfer a product licence, also known as a marketing authorisation, to a different owner.
Accord Healthcare Limited, UK has informed the MHRA that the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SPC) do not contain all the required safety information.
Cancel a marketing authorisation, traditional herbal registration or parallel import product licence or withdraw a pending submission.
Decisions made by the MHRA following investigations into complaints about advertising for licensed medicines.